Ransomware victim disclosure
← All victimsSpectrum Solutions LLC
Claimed by Alphv · listed 3 years ago
Status timeline
- ListedNov 24, 2023
- Data leakeddate unknown
At a glance
- Group
- Alphv
- Status
- Data leaked
- Sector
- Consumer Services
- Listed on leak site
- Nov 24, 2023
About the victim
AI dossier — public-source company profileSpectrum Solutions LLC is a medical device engineering and contract manufacturing company founded in 2006, specializing in innovative diagnostic solutions. The company is particularly known for pioneering saliva-based COVID-19 testing and holds FDA Emergency Use Authorization for its SDNA-1000 saliva collection device. They provide contract manufacturing, product development, and diagnostic assay licensing services to the life sciences sector.
- Industry
- Medical Device Manufacturing & Contract Manufacturing
- Founded
- 2006
Attack summary
Severity: medium — Medical device manufacturer with sensitive business operations (FDA-authorized products, contract manufacturing details, research programs) appears compromised. No specific PII at scale, regulated health data, or financial records are explicitly mentioned as published, but the company handles regulated medical devices and likely possesses customer/patient data from diagnostics operations. The disclosed content is marketing material only.ALPHV claims to have exfiltrated data from Spectrum Solutions. The group has published the company's own marketing content describing their operations, products, and innovations in medical devices and diagnostics.
Data the group says was taken
AI dossier — extracted from the leak post- Company marketing materials
- Product information
- Business descriptions
What the group claims
Our Story Since 2006, Spectrum Solutions has been a single-source provider of high-quality, direct-to-consumer product innovation & global fulfillment. For the last decade, Spectrum has found a specialized focus in the medical science sector that includes the engineering and manufacturing of industry innovating medical devices. Spectrum’s innovation has made such an impact within the life science sector it has been honored with several prestigious awards, received incredible industry and private sector recognition, and is directly responsible for the birth of a new billion-dollar saliva diagnostic industry. We engineer and have medical device contract manufacturing, actively participate in medical science research programs, develop, and license diagnostic testing assays, we are uniquely able to offer our contract manufacturing and MedTech outsourcing customers measurable process optimization, a shorter time to market window, unmatched scalability, and full product development-to-delivery solutions. Sometimes a fresh perspective on something we thought we understood, can open the door of new possibilities we hadn’t even considered. Focused on pioneering medical device innovation, Spectrum Solutions commissioned the breakthrough saliva study that dared to suggest a complete transformation in viral PCR testing protocols to an easier, pain-free, non-invasive, 99.998% accurate, and infinitely safer option using saliva (spit). Saliva’s recent MVP status is a new development even though saliva’s been used in diagnostics for more than 2000 years. Analysis of the properties in saliva using biochemical and physiological methodologies are traced back to at least a century ago. Unlike blood, saliva analysis looks at the cellular level (the biologically active compounds), making it a better representative of what is clinically relevant. Years from now, the medical community, patients, and history books will look back on 2020 and COVID-19 testing as the diagnostic turning point in favor of saliva. In affirmation of this diagnostic innovation pivot, a speedy and unprecedented FDA response secured the first Emergency Use Authorization (EUA) early March 2020, for the use of saliva, solely collected using the Spectrum SDNA-1000, as a diagnostic biomaterial for COVID-19 testing. A few weeks later, requests for additional product and process information to further validate safety and sample efficacy in extended storage and transport scenarios. The device’s remarkable performance locked in the FDA’s first direct-to-patient at-home testing authorization for the self-collection of saliva. A timely decision that drove product integration both nationwide and globally. Saliva collected using a Spectrum bio-sample collection system creates the most robust and safest testing biomaterial. We believe when you bridge the gap between science and real medical solutions you deliver innovation with the practical power to impact and change outcomes. Our products, services, and expertise are paving the way and pioneering a new era of direct-to-consumer health & wellness, point-of-care, and at-home molecular diagnostic testing.
Sources
Source
Indexed 3 years agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
Is this your supplier? Your competitor? You?
Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

